Tudor Investment Corp’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,160,841
Closed -$5.85M 2122
2023
Q1
$5.85M Buy
+3,160,841
New +$5.85M 0.09% 279
2017
Q2
Sell
-100,000
Closed -$2.2M 1443
2017
Q1
$2.2M Buy
+100,000
New +$2.2M 0.07% 174